Effect of Caprylic, Capric and Oleic Acid on Growth of Rumen and Rabbit Caecal Bacteria*
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Thermal Stability of Oleic Acid and Ethyl Linoleate
Chapter 3.1 ____________________________________________________________________ Thermal Stability of Oleic Acid and Ethyl Linoleate The first part of this work consisted of studying the thermal stability of oleic acid, which was initially a candidate as a starting material for the dehydrogenation of fatty acids using heterogeneous catalysis. The results induced us to search another starting material and to study its properties. 3.1.1 Introduction Oil-derived products can be subjected to conditions that promote oxidation of their unsaturated components during storage and use. The materials arising during oxidation and subsequent degradation can seriously impair the quality and performance of such products [1, 2]. Thus, oxidative stability is an important issue to face before studying their catalytic reactivity. The fatty acid alkyl chain is susceptible to oxidation both at double bonds and adjacent allylic carbons. Free-radical and photooxidation at allylic carbons are responsible for deterioration of unsaturated oils and fats [2-6]. Both autoxidation and photooxidation produce hydroperoxides in allylic bonds. During this process, the position and geometry of the double bond may change. The hydroperoxide mixtures produced by autoxidation and photooxidation are not identical, indicating that different mechanisms are involved [4-6]. The autoxidation reaction occurs in the presence of oxygen. Autoxidation is a free-radical chain reaction, which involves the series of reactions that initiate, propagate and terminate the chain [3]. • initiation RH → R • + → • propagation R O2 ROO fast • • ROO + RH → ROOH + R rate determining • • termination R , ROO → stable products The initiator is a free radical, most probably produced by decomposition of hydroperoxides already present or produced by photooxidation. -
Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis
International Journal of Molecular Sciences Review Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis David Johane Machate 1, Priscila Silva Figueiredo 2 , Gabriela Marcelino 2 , Rita de Cássia Avellaneda Guimarães 2,*, Priscila Aiko Hiane 2 , Danielle Bogo 2, Verônica Assalin Zorgetto Pinheiro 2, Lincoln Carlos Silva de Oliveira 3 and Arnildo Pott 1 1 Graduate Program in Biotechnology and Biodiversity in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] (D.J.M.); [email protected] (A.P.) 2 Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; pri.fi[email protected] (P.S.F.); [email protected] (G.M.); [email protected] (P.A.H.); [email protected] (D.B.); [email protected] (V.A.Z.P.) 3 Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-67-3345-7416 Received: 9 March 2020; Accepted: 27 March 2020; Published: 8 June 2020 Abstract: Long-term high-fat dietary intake plays a crucial role in the composition of gut microbiota in animal models and human subjects, which affect directly short-chain fatty acid (SCFA) production and host health. This review aims to highlight the interplay of fatty acid (FA) intake and gut microbiota composition and its interaction with hosts in health promotion and obesity prevention and its related metabolic dysbiosis. -
Fatty Acids: Essential…Therapeutic
Volume 3, No.2 May/June 2000 A CONCISE UPDATE OF IMPORTANT ISSUES CONCERNING NATURAL HEALTH INGREDIENTS Written and Edited By: Thomas G. Guilliams Ph.D. FATTY ACIDS: Essential...Therapeutic Few things have been as confusing to both patient and health care provider as the issue of fats and oils. Of all the essential nutrients required for optimal health, fatty acids have not only been forgotten they have been considered hazardous. Health has somehow been equated with “low-fat” or “fat-free” for so long, to suggest that fats could be essential or even therapeutic is to risk credibility. We hope to give a view of fats that is both balanced and scientific. This review will cover the basics of most fats that will be encountered in dietary or supplemental protocols. Recommendations to view essential fatty acids in a similar fashion as essential vitamins and minerals will be combined with therapeutic protocols for conditions ranging from cardiovascular disease, skin conditions, diabetes, nerve related disorders, retinal disorders and more. A complete restoration of health cannot be accomplished until there is a restoration of fatty acid nutritional information among health care professionals and their patients. Fats- What are they? Dietary fats come to us from a variety of sources, but primarily in the form of triglycerides. That is, three fatty acid molecules connected by a glycerol backbone (see fatty acid primer page 3 for diagram). These fatty acids are then used as energy by our cells or modified into phospholipids to be used as cell or organelle membranes. Some fatty acids are used in lipoprotein molecules to shuttle cholesterol and fats to and from cells, and fats may also be stored for later use. -
Relationship Between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients
Relationship between Dietary Intake of Fatty Acids and Disease Activity in Pediatric Inflammatory Bowel Disease Patients A thesis submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Master of Science in the Department of Nutrition of the College of Allied Health Sciences by Michael R. Ciresi B.S. The Ohio State University June 2008 Committee Chair: Grace Falciglia, Ph.D. Abstract Background. Crohn’s disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel disease (IBD), are chronic illnesses that affect predominately the gastrointestinal tract. The pathogenesis and etiology remain unclear but the importance of environmental factors, in particular diet, is evidenced by the increased incidence rates of the recent decades that genetic inheritance cannot account for. In particular, the quantity of fatty acid consumption has been consistently linked with IBD risk. While several studies have investigated the connections between diet, etiology, signs and symptoms associated with IBD, very few have explored the relationship between disease state and specific fatty acid intake in the pediatric IBD population. Methods. In this cross-sectional study, 100 pediatric patients from Cincinnati Children’s Hospital and the Hospital for Sick Children in Toronto with diagnosed IBD (73 with Crohn’s disease (CD) and 27 with ulcerative colitis (UC)) were included. Three-day diet records were collected from the patients for the assessment of their dietary intake. The abbreviated Pediatric Crohn’s Disease Activity Index (PCDAI), the abbreviated Ulcerative Colitis Activity Index (PUCAI), and markers of inflammation (lipopolysaccharide binding protein (LBP) and S100A12) were used to assess disease severity. -
(12) United States Patent (10) Patent No.: US 8,187,615 B2 Friedman (45) Date of Patent: May 29, 2012
US008187615B2 (12) United States Patent (10) Patent No.: US 8,187,615 B2 Friedman (45) Date of Patent: May 29, 2012 (54) NON-AQUEOUS COMPOSITIONS FOR ORAL 6,054,136 A 4/2000 Farah et al. DELIVERY OF INSOLUBLE BOACTIVE 6,140,375 A 10/2000 Nagahama et al. AGENTS 2003/O149061 A1* 8/2003 Nishihara et al. .......... 514,266.3 FOREIGN PATENT DOCUMENTS (76) Inventor: Doron Friedman, Karme-Yosef (IL) GB 2222770 A 3, 1990 JP 2002-121929 5, 1990 (*) Notice: Subject to any disclaimer, the term of this WO 96,13273 * 5/1996 patent is extended or adjusted under 35 WO 200056346 A1 9, 2000 U.S.C. 154(b) by 1443 days. OTHER PUBLICATIONS (21) Appl. No.: 10/585,298 Pouton, “Formulation of Self-Emulsifying Drug Delivery Systems' Advanced Drug Delivery Reviews, 25:47-58 (1997). (22) PCT Filed: Dec. 19, 2004 Lawrence and Rees, “Microemulsion-based media as novel drug delivery systems' Advanced Drug Delivery Reviews, 45:89-121 (86). PCT No.: PCT/L2004/OO1144. (2000). He et al., “Microemulsions as drug delivery systems to improve the S371 (c)(1), solubility and the bioavailability of poorly water-soluble drugs' (2), (4) Date: Jul. 6, 2006 Expert Opin. Drug Deliv. 7:445-460 (2010). Prajpati et al. “Effect of differences in Fatty Acid Chain Lengths of (87) PCT Pub. No.: WO2005/065652 Medium-Chain Lipids on Lipid/Surfactant/Water Phase Diagrams PCT Pub. Date: Jul. 21, 2005 and Drug Solubility” J. Excipients and Food Chem, 2:73-88 (2011). (65) Prior Publication Data * cited by examiner US 2007/O190O80 A1 Aug. -
Valorization of Glycerol Through the Enzymatic Synthesis of Acylglycerides with High Nutritional Value
catalysts Article Valorization of Glycerol through the Enzymatic Synthesis of Acylglycerides with High Nutritional Value Daniel Alberto Sánchez 1,3,* , Gabriela Marta Tonetto 1,3 and María Luján Ferreira 2,3 1 Departamento de Ingeniería Química, Universidad Nacional del Sur (UNS), Bahía Blanca 8000, Argentina; [email protected] 2 Departamento de Química, Universidad Nacional del Sur (UNS), Bahía Blanca 8000, Argentina; [email protected] 3 Planta Piloto de Ingeniería Química–PLAPIQUI (UNS-CONICET), Bahía Blanca 8000, Argentina * Correspondence: [email protected]; Tel.: +54-291-4861700 Received: 8 December 2019; Accepted: 1 January 2020; Published: 14 January 2020 Abstract: The production of specific acylglycerides from the selective esterification of glycerol is an attractive alternative for the valorization of this by-product of the biodiesel industry. In this way, products with high added value are generated, increasing the profitability of the overall process and reducing an associated environmental threat. In this work, nutritional and medically interesting glycerides were obtained by enzymatic esterification through a two-stage process. In the first stage, 1,3-dicaprin was obtained by the regioselective esterification of glycerol and capric acid mediated by the commercial biocatalyst Lipozyme RM IM. Under optimal reaction conditions, 73% conversion of fatty acids and 76% selectivity to 1,3-dicaprin was achieved. A new model to explain the participation of lipase in the acyl migration reaction is presented. It evaluates the conditions in the microenvironment of the active site of the enzyme during the formation of the tetrahedral intermediate. In the second stage, the esterification of the sn-2 position of 1,3-dicaprin with palmitic acid was performed using the lipase from Burkholderia cepacia immobilized on chitosan as the biocatalyst. -
Fats and Fatty Acid in Human Nutrition
ISSN 0254-4725 91 FAO Fats and fatty acids FOOD AND NUTRITION PAPER in human nutrition Report of an expert consultation 91 Fats and fatty acids in human nutrition − Report of an expert consultation Knowledge of the role of fatty acids in determining health and nutritional well-being has expanded dramatically in the past 15 years. In November 2008, an international consultation of experts was convened to consider recent scientific developments, particularly with respect to the role of fatty acids in neonatal and infant growth and development, health maintenance, the prevention of cardiovascular disease, diabetes, cancers and age-related functional decline. This report will be a useful reference for nutrition scientists, medical researchers, designers of public health interventions and food producers. ISBN 978-92-5-106733-8 ISSN 0254-4725 9 7 8 9 2 5 1 0 6 7 3 3 8 Food and Agriculture I1953E/1/11.10 Organization of FAO the United Nations FAO Fats and fatty acids FOOD AND NUTRITION in human nutrition PAPER Report of an expert consultation 91 10 − 14 November 2008 Geneva FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 2010 The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) concerning the legal or development status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these have been endorsed or recommended by FAO in preference to others of a similar nature that are not mentioned. -
Medium-Chain Fatty Acids and Monoglycerides As Feed Additives for Pig Production: Towards Gut Health Improvement and Feed Pathogen Mitigation Joshua A
Jackman et al. Journal of Animal Science and Biotechnology (2020) 11:44 https://doi.org/10.1186/s40104-020-00446-1 REVIEW Open Access Medium-chain fatty acids and monoglycerides as feed additives for pig production: towards gut health improvement and feed pathogen mitigation Joshua A. Jackman1*, R. Dean Boyd2,3 and Charles C. Elrod4,5* Abstract Ongoing challenges in the swine industry, such as reduced access to antibiotics and virus outbreaks (e.g., porcine epidemic diarrhea virus, African swine fever virus), have prompted calls for innovative feed additives to support pig production. Medium-chain fatty acids (MCFAs) and monoglycerides have emerged as a potential option due to key molecular features and versatile functions, including inhibitory activity against viral and bacterial pathogens. In this review, we summarize recent studies examining the potential of MCFAs and monoglycerides as feed additives to improve pig gut health and to mitigate feed pathogens. The molecular properties and biological functions of MCFAs and monoglycerides are first introduced along with an overview of intervention needs at different stages of pig production. The latest progress in testing MCFAs and monoglycerides as feed additives in pig diets is then presented, and their effects on a wide range of production issues, such as growth performance, pathogenic infections, and gut health, are covered. The utilization of MCFAs and monoglycerides together with other feed additives such as organic acids and probiotics is also described, along with advances in molecular encapsulation and delivery strategies. Finally, we discuss how MCFAs and monoglycerides demonstrate potential for feed pathogen mitigation to curb disease transmission. Looking forward, we envision that MCFAs and monoglycerides may become an important class of feed additives in pig production for gut health improvement and feed pathogen mitigation. -
Sweet Almond Oil Organic
SWEET ALMOND OIL ORGANIC PRODUCT DATA SHEET SWEET ALMOND OIL ORGANIC is a Vegetable Oil obtained from the dried kernels of the almond tree. Almonds contain folic acid, alpha tocopherol and zinc, which are useful for the treatment of skin disorders. It has been used for centuries both medicinally and cosmetically as a muscle- relaxer, cleanser and moisturizer to name just a few of its applications. SWEET ALMOND OIL is high in mono and polyunsaturated fatty acids, minerals and glycosides. Fatty acids are necessary along with glycerol for the cell to function normally. SWEET ALMOND OIL ORGANIC also contains vitamins A, B1, B2, B6 with small amounts of Vitamin E and D. Due to the presence of Vitamin E the oil has antioxidant capability. Antioxidants protect vital cell structures by neutralizing free radicals. Topical vitamin E has shown to have a wide variety of skin benefits. Many studies have shown that it can help decrease the effects of psoriasis, erythema, and may help in reducing the risk of skin cancer. Vitamin E also helps in the reduction of scaring from wounds and on the appearance of stretch marks on the skin. TECHNICAL DATA Appearance: Pale yellow, oily liquid with minimum odour Acidity index: 1.0 mg KOH/g oil Peroxide value: 20.0 meq O2/Kg oil Specific gravity: 0.90 - 0.93 g/ml Updated: 01/2007 Approved: Dr. Blanca Martínez SWEET ALMOND OIL ORGANIC SWEET ALMOND OIL ORGANIC Fatty acids composition (Fatty Acid Fraction): Oleic acid 62.0 - 86.0 % Linoleic acid ( )7.0-30.0% Palmitic acid 4.0 - 9.0 % Stearic acid Max. -
Preparation and Properties of Capric–Myristic Acid/Expanded Graphite Composite Phase Change Materials for Latent Heat Thermal Energy Storage
energies Article Preparation and Properties of Capric–Myristic Acid/Expanded Graphite Composite Phase Change Materials for Latent Heat Thermal Energy Storage Dongyi Zhou 1,2,3, Jiawei Yuan 2, Yuhong Zhou 2 and Yicai Liu 1,* 1 School of Energy Science and Engineering, Central South University, Changsha 410083, China; [email protected] 2 School of Mechanical and Energy Engineering, Shaoyang University, Shaoyang 422000, China; [email protected] (J.Y.); [email protected] (Y.Z.) 3 Key Laboratory of Hunan Province for Efficient Power System and Intelligent Manufacturing, Shaoyang University, Shaoyang 422000, China * Correspondence: [email protected]; Tel.: +86-0731-8887-6111 Received: 9 April 2020; Accepted: 6 May 2020; Published: 14 May 2020 Abstract: A novel composite phase change material (CPCM), capric–myristic acid/expanded graphite (CA–MA/EG) CPCM, was prepared by absorbing liquid CA–MA (as the phase change material (PCM)) into EG (as the substrate material) for heat storage in the backfill materials of soil-source heat pump systems. The thermal characteristics and microstructure of the novel CPCM were analyzed using differential scanning calorimetry (DSC) and scanning electronic microscopy (SEM). The thermal conductivities of CA–MA/EG CPCM were surveyed. The thermal stability of the CA–MA/EG was analyzed using thermogravimetric analysis (TGA) and thermal cycle tests. The results showed that the optimal mass content of CA–MA in CPCM was approximately 92.4% and the CA–MA was uniformly distributed in the vesicular structure of EG; the CA–MA/EG CPCM had an appropriate phase change temperature (Tm: 19.78 ◦C, Tf: 18.85 ◦C), high latent heat (Hm: 137.3 J/g, Hf: 139.9 J/g), and excellent thermostability and thermal reliability. -
Fatty Acid Composition of Nuts – Implications for Cardiovascular Health
British Journal of Nutrition (2006), 96, Suppl. 2, S29–S35 DOI: 10.1017/BJN20061861 q The Authors 2006 Fatty acid composition of nuts – implications for cardiovascular health Emilio Ros1* and Jose´ Mataix2 1Unitat de Lı´pids, Sevei d’Endocrinologia i Nutricio´, Institut d’Investigacions Biome`diques August Pi Sunyer, Hospital Clı´nic, Barcelona, Spain 2Instituto de Nutricio´n y Tecnologı´a de los Alimentos, Universidad de Granada, Granada, Spain It is well established that, due to their high content of saturated fatty acids (SFA), the intake of meat and meat products is strongly associated with elevated blood cholesterol concentrations and an increased risk of hypertension, diabetes and cardiovascular diseases. Conversely, the intake of foods rich in unsaturated fatty acids, such as those contained in most vegetable fats and oils and oily fish, is associated with improved lipid profiles, a lower potency of intermediate biomarkers of atherosclerosis and lesser incidence of cardiovascular diseases. There are persuasive evidences that dietary substitution of monounsaturated fatty acids (MUFA) or n-6 polyunsaturated fatty acids (PUFA) for SFA lowers blood cholesterol and may have beneficial effects on inflammation, thrombosis, and vascular reactivity. MUFA may have an advantage over PUFA because enrichment of lipoprotein lipids with MUFA increases their resistance to oxidation. Marine n-3 PUFA have a number of anti-atherosclerotic effects, including anti-arrhythmic properties and, at relatively high doses, reduce serum triglycerides. These effects appear to be shared in part by vegetable n-3 PUFA. Nuts are natural foods rich in unsaturated fatty acids; most nuts contain substantial amounts of MUFA, while walnuts are especially rich in both n-6 and n-3 PUFA. -
Comparison of an Oleic Acid Enriched-Diet Vs NCEP-I Diet on LDL Susceptibility to Oxidative Modi®Cations
European Journal of Clinical Nutrition (2000) 54, 61±67 ß 2000 Macmillan Publishers Ltd. All rights reserved 0954±3007/00 $15.00 www.nature.com/ejcn Comparison of an oleic acid enriched-diet vs NCEP-I diet on LDL susceptibility to oxidative modi®cations P Castro1,JLoÂpez Miranda1,PGoÂmez1, DM Escalante1,FLoÂpez Segura1, A MartõÂn2, F Fuentes1, AÂ Blanco1, JM OrdovaÂs2 and FP JimeÂnez1* 1Lipids Research Unit, Hospital University Reina So®a, Medical School, University of CoÂrdoba, Spain; and 2The Lipid Metabolism Laboratory, USDA, Human Nutrition Research Center on Aging at Tufts University, Boston, USA Objective: The objective of this trial was to compare the effect on the susceptibility of plasma Low Density Lipoprotein (LDL) to oxidative modi®cations of consumption of two oleic rich diets, prepared with two different plant oils, virgin olive oil (OL)1 and re®ned high monounsaturated fatty acids (MUFA sun¯ower oil (SU)), with the susceptibility of plasma LDL to oxidation after an National Cholesterol Education Program step 1 (NCEP-I) phase diet. Design: A randomized crossover design. Subjects and interventions: Twenty-two healthy normolipidemic young males consumed an NCEP-I diet for a 4-week period. Subjects were then assigned to two diets each of 4-weeks duration. Group one was placed on an olive oil enriched diet (40% fat, 22% MUFA) followed by a 4-week period of a MUFA diet enriched in sun¯ower oil (40% fat, 22% MUFA). In group two, the order of the diets was reversed. Results: Both MUFA diets induced a decrease in saturated (14 : 0, 16 : 0, and 18 : 0) and an increase in monounsaturated and polyunsaturated n-6 (18 : 2, 20 : 3, and 20 : 5) plasma LDL-phospholipid fatty acids, compared to the NCEP-I diet (P < 0.01).